Skip to content

Comparative Effectiveness of Sharbat-e-Toot Siyah with Laooq Katan in the treatment of Waram-i-Halaq Muzmin (Chronic Pharyngitis)

A comparative study of Sharbat-e-Toot Siyah with Laooq Katan in the management of Waram-i-Halaq Muzmin (Chronic Pharyngitis)-A randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071889
Enrollment
60
Registered
2024-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J312- Chronic pharyngitis

Interventions

Intervention1: Sharbat-e-Toot Siyah: Sharbat-e-Toot Siyah will be provided to patients in a dosage of 25 ml twice daily for 6 weeks. Control Intervention1: Laooq Katan: Laooq Katan will be provided to

Sponsors

State Unani Medical College and HAHRDM Hospital Prayagraj Uttar Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Presence of all the following signs and symptoms of Waram-i-halaq • Surfa Yubsiyya (Dry Cough) • Buhha-al-Sawt (Hoarseness of Voice) • Waja-e-halaq (Odynophagia) • Usr-al-Bala (Dysphagia) • Humama Bulum (Pharyngeal Erythema) • Khushuna-al-Halaq (Irritation in throat) • Clincal Diagnosed Cases of Waram-i-halaq Muzmin

Exclusion criteria

Exclusion criteria: Presence of any one of the following: Patients with all four classical symptoms of Group A streptococcal pharyngitis: • Pharyngeal or Tonsillar exudates • swollen anterior cervical nodes • History of fever more than 38 ? C • Absence of cough • Known cases of Renal/Hepatic/Cardiac ailments/Diabetes mellitus • Pregnant and lactating women • Oral candidiasis, Epiglottitis, Herpes simplex, Mononucleosis, Gastro oesophageal reflux

Design outcomes

Primary

MeasureTime frame
Efficacy will be assessed clinically by improvement in clinical features, and swab culture.Timepoint: Day 0, 7, 14, 21, 28, 35 and 42.

Secondary

MeasureTime frame
Improvement in Clinical Signs and SymptomsTimepoint: day 0 and day 42

Countries

India

Contacts

Public ContactDr Mohd Asif Hussain Usmani

State Unani Medical College And Hospital

arogyaherbal@gmail.com9415639877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026